APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Tools for Cancer Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Tools for Cancer Therapy Market Outlook and Growth Opportunities 2026

3 July 2026219 pages

Choose your research edition.

Industry ResearchAI Tools for Cancer Therapy Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Tools for Cancer Therapy Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal AI Tools for Cancer Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Tools for Cancer Therapy Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Tools for Cancer Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global AI Tools for Cancer Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Tools for Cancer Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Tools for Cancer Therapy market include Siemens Healthineers, GE Healthcare, ConcertAI, Medtronic, Roche, Oracle, NVIDIA, Philips and PathAI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Tools for Cancer Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Tools for Cancer Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Tools for Cancer Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Tools for Cancer Therapy market.

AI Tools for Cancer Therapy Segment by Company

Siemens Healthineers

GE Healthcare

ConcertAI

Medtronic

Roche

Oracle

NVIDIA

Philips

PathAI

CureMetrix

Mindpeak

Paige AI

Predictive Oncology

Exscientia

Insilico Medicine

Iktos

Tempus

Azra AI

CureMatch

OncoLens

Triomics

Clinakos

Perthera

Cellworks Group

Biomy

AI Tools for Cancer Therapy Segment by Type

Solid Tumors

Hematological Malignancies

Others

AI Tools for Cancer Therapy Segment by Application

Hospitals

Pharmaceuticals

Research Institutes

Others

AI Tools for Cancer Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Tools for Cancer Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Tools for Cancer Therapy key companies, revenue, market share, and recent developments.

3. To split the AI Tools for Cancer Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Tools for Cancer Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Tools for Cancer Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze AI Tools for Cancer Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Tools for Cancer Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Tools for Cancer Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Tools for Cancer Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Tools for Cancer Therapy industry.

Chapter 3: Detailed analysis of AI Tools for Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Tools for Cancer Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Tools for Cancer Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Tools for Cancer Therapy Industry Trends Table 2. AI Tools for Cancer Therapy Industry Drivers Table 3. AI Tools for Cancer Therapy Industry Opportunities and Challenges Table 4. AI Tools for Cancer Therapy Industry Restraints Table 5. Global AI Tools for Cancer Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Tools for Cancer Therapy Revenue Share by Company (2021-2026) Table 7. Global AI Tools for Cancer Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Tools for Cancer Therapy Key Company Manufacturing Base & Headquarters Table 9. Global AI Tools for Cancer Therapy Company, Product Type & Application Table 10. Global AI Tools for Cancer Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Tools for Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Solid Tumors Table 15. Significant Companies of Hematological Malignancies Table 16. Significant Companies of Others Table 17. Global AI Tools for Cancer Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global AI Tools for Cancer Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global AI Tools for Cancer Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global AI Tools for Cancer Therapy Sales Value Share by Type (2021-2026) Table 21. Global AI Tools for Cancer Therapy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Pharmaceuticals Table 24. Significant Companies of Research Institutes Table 25. Significant Companies of Others Table 26. Global AI Tools for Cancer Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Tools for Cancer Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Tools for Cancer Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Tools for Cancer Therapy Sales Value Share by Application (2021-2026) Table 30. Global AI Tools for Cancer Therapy Sales Value Share by Application (2027-2032) Table 31. Global AI Tools for Cancer Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Tools for Cancer Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Tools for Cancer Therapy Sales Value Share by Region (2021-2026) Table 34. Global AI Tools for Cancer Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Tools for Cancer Therapy Sales Value Share by Region (2027-2032) Table 36. Global AI Tools for Cancer Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Tools for Cancer Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Tools for Cancer Therapy Sales Value Market Share by Country (2021-2026) Table 39. Global AI Tools for Cancer Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Tools for Cancer Therapy Sales Value Market Share by Country (2027-2032) Table 41. Siemens Healthineers Company Information Table 42. Siemens Healthineers Business Overview Table 43. Siemens Healthineers AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio Table 45. Siemens Healthineers Recent Development Table 46. GE Healthcare Company Information Table 47. GE Healthcare Business Overview Table 48. GE Healthcare AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GE Healthcare AI Tools for Cancer Therapy Product Portfolio Table 50. GE Healthcare Recent Development Table 51. ConcertAI Company Information Table 52. ConcertAI Business Overview Table 53. ConcertAI AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. ConcertAI AI Tools for Cancer Therapy Product Portfolio Table 55. ConcertAI Recent Development Table 56. Medtronic Company Information Table 57. Medtronic Business Overview Table 58. Medtronic AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Medtronic AI Tools for Cancer Therapy Product Portfolio Table 60. Medtronic Recent Development Table 61. Roche Company Information Table 62. Roche Business Overview Table 63. Roche AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Roche AI Tools for Cancer Therapy Product Portfolio Table 65. Roche Recent Development Table 66. Oracle Company Information Table 67. Oracle Business Overview Table 68. Oracle AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Oracle AI Tools for Cancer Therapy Product Portfolio Table 70. Oracle Recent Development Table 71. NVIDIA Company Information Table 72. NVIDIA Business Overview Table 73. NVIDIA AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. NVIDIA AI Tools for Cancer Therapy Product Portfolio Table 75. NVIDIA Recent Development Table 76. Philips Company Information Table 77. Philips Business Overview Table 78. Philips AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Philips AI Tools for Cancer Therapy Product Portfolio Table 80. Philips Recent Development Table 81. PathAI Company Information Table 82. PathAI Business Overview Table 83. PathAI AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. PathAI AI Tools for Cancer Therapy Product Portfolio Table 85. PathAI Recent Development Table 86. CureMetrix Company Information Table 87. CureMetrix Business Overview Table 88. CureMetrix AI Tools for Cancer Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CureMetrix AI Tools for Cancer Therapy Product Portfolio Table 90. CureMetrix Recent Development Table 91. Mindpeak Company Information Table 92. Mindpeak Business Overview Table 93. Mindpeak AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Mindpeak AI Tools for Cancer Therapy Product Portfolio Table 95. Mindpeak Recent Development Table 96. Paige AI Company Information Table 97. Paige AI Business Overview Table 98. Paige AI AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Paige AI AI Tools for Cancer Therapy Product Portfolio Table 100. Paige AI Recent Development Table 101. Predictive Oncology Company Information Table 102. Predictive Oncology Business Overview Table 103. Predictive Oncology AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Predictive Oncology AI Tools for Cancer Therapy Product Portfolio Table 105. Predictive Oncology Recent Development Table 106. Exscientia Company Information Table 107. Exscientia Business Overview Table 108. Exscientia AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Exscientia AI Tools for Cancer Therapy Product Portfolio Table 110. Exscientia Recent Development Table 111. Insilico Medicine Company Information Table 112. Insilico Medicine Business Overview Table 113. Insilico Medicine AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Insilico Medicine AI Tools for Cancer Therapy Product Portfolio Table 115. Insilico Medicine Recent Development Table 116. Iktos Company Information Table 117. Iktos Business Overview Table 118. Iktos AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Iktos AI Tools for Cancer Therapy Product Portfolio Table 120. Iktos Recent Development Table 121. Tempus Company Information Table 122. Tempus Business Overview Table 123. Tempus AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Tempus AI Tools for Cancer Therapy Product Portfolio Table 125. Tempus Recent Development Table 126. Azra AI Company Information Table 127. Azra AI Business Overview Table 128. Azra AI AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Azra AI AI Tools for Cancer Therapy Product Portfolio Table 130. Azra AI Recent Development Table 131. CureMatch Company Information Table 132. CureMatch Business Overview Table 133. CureMatch AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. CureMatch AI Tools for Cancer Therapy Product Portfolio Table 135. CureMatch Recent Development Table 136. OncoLens Company Information Table 137. OncoLens Business Overview Table 138. OncoLens AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. OncoLens AI Tools for Cancer Therapy Product Portfolio Table 140. OncoLens Recent Development Table 141. Triomics Company Information Table 142. Triomics Business Overview Table 143. Triomics AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Triomics AI Tools for Cancer Therapy Product Portfolio Table 145. Triomics Recent Development Table 146. Clinakos Company Information Table 147. Clinakos Business Overview Table 148. Clinakos AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Clinakos AI Tools for Cancer Therapy Product Portfolio Table 150. Clinakos Recent Development Table 151. Perthera Company Information Table 152. Perthera Business Overview Table 153. Perthera AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Perthera AI Tools for Cancer Therapy Product Portfolio Table 155. Perthera Recent Development Table 156. Cellworks Group Company Information Table 157. Cellworks Group Business Overview Table 158. Cellworks Group AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Cellworks Group AI Tools for Cancer Therapy Product Portfolio Table 160. Cellworks Group Recent Development Table 161. Biomy Company Information Table 162. Biomy Business Overview Table 163. Biomy AI Tools for Cancer Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Biomy AI Tools for Cancer Therapy Product Portfolio Table 165. Biomy Recent Development Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. AI Tools for Cancer Therapy Product Image Figure 2. Global AI Tools for Cancer Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Tools for Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Tools for Cancer Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Solid Tumors Image Figure 8. Hematological Malignancies Image Figure 9. Others Image Figure 10. Global AI Tools for Cancer Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global AI Tools for Cancer Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global AI Tools for Cancer Therapy Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Pharmaceuticals Image Figure 15. Research Institutes Image Figure 16. Others Image Figure 17. Global AI Tools for Cancer Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Tools for Cancer Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Tools for Cancer Therapy Sales Value Share by Application (2021-2032) Figure 20. Global AI Tools for Cancer Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Tools for Cancer Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Tools for Cancer Therapy Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Tools for Cancer Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Tools for Cancer Therapy Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Tools for Cancer Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Tools for Cancer Therapy Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Tools for Cancer Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Tools for Cancer Therapy Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Tools for Cancer Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Tools for Cancer Therapy Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Tools for Cancer Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Tumors
  • Hematological Malignancies
  • Others
Applications
  • Hospitals
  • Pharmaceuticals
  • Research Institutes
  • Others
Companies covered
  • Siemens Healthineers
  • GE Healthcare
  • ConcertAI
  • Medtronic
  • Roche
  • Oracle
  • NVIDIA
  • Philips
  • PathAI
  • CureMetrix
  • Mindpeak
  • Paige AI
  • Predictive Oncology
  • Exscientia
  • Insilico Medicine
  • Iktos
  • Tempus
  • Azra AI
  • CureMatch
  • OncoLens
  • Triomics
  • Clinakos
  • Perthera
  • Cellworks Group
  • Biomy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Tools for Cancer Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Tools for Cancer Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Tools for Cancer Therapy Market Dynamics
  1. 2.1 AI Tools for Cancer Therapy Industry Trends
  2. 2.2 AI Tools for Cancer Therapy Industry Drivers
  3. 2.3 AI Tools for Cancer Therapy Industry Opportunities and Challenges
  4. 2.4 AI Tools for Cancer Therapy Industry Restraints
3 AI Tools for Cancer Therapy Market by Company
  1. 3.1 Global AI Tools for Cancer Therapy Company Revenue Ranking in 2025
  2. 3.2 Global AI Tools for Cancer Therapy Revenue by Company (2021-2026)
  3. 3.3 Global AI Tools for Cancer Therapy Company Ranking (2024-2026)
  4. 3.4 Global AI Tools for Cancer Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Tools for Cancer Therapy Company Product Type and Application
  6. 3.6 Global AI Tools for Cancer Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Tools for Cancer Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Tools for Cancer Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Tools for Cancer Therapy Market by Type
  1. 4.1 AI Tools for Cancer Therapy Type Introduction
  2. 4.1.1 Solid Tumors
  3. 4.1.2 Hematological Malignancies
  4. 4.1.3 Others
  5. 4.2 Global AI Tools for Cancer Therapy Sales Value by Type
  6. 4.2.1 Global AI Tools for Cancer Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global AI Tools for Cancer Therapy Sales Value by Type (2021-2032)
  8. 4.2.3 Global AI Tools for Cancer Therapy Sales Value Share by Type (2021-2032)
5 AI Tools for Cancer Therapy Market by Application
  1. 5.1 AI Tools for Cancer Therapy Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global AI Tools for Cancer Therapy Sales Value by Application
  7. 5.2.1 Global AI Tools for Cancer Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Tools for Cancer Therapy Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Tools for Cancer Therapy Sales Value Share by Application (2021-2032)
6 AI Tools for Cancer Therapy Regional Value Analysis
  1. 6.1 Global AI Tools for Cancer Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Tools for Cancer Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Tools for Cancer Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Tools for Cancer Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Tools for Cancer Therapy Sales Value (2021-2032)
  7. 6.3.2 North America AI Tools for Cancer Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Tools for Cancer Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe AI Tools for Cancer Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Tools for Cancer Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Tools for Cancer Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Tools for Cancer Therapy Sales Value (2021-2032)
  16. 6.6.2 South America AI Tools for Cancer Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Tools for Cancer Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Tools for Cancer Therapy Sales Value Share by Country, 2025 VS 2032
7 AI Tools for Cancer Therapy Country-level Value Analysis
  1. 7.1 Global AI Tools for Cancer Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Tools for Cancer Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Tools for Cancer Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Tools for Cancer Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Tools for Cancer Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Tools for Cancer Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Tools for Cancer Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens Healthineers
  2. 8.1.1 Siemens Healthineers Company Information
  3. 8.1.2 Siemens Healthineers Business Overview
  4. 8.1.3 Siemens Healthineers AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio
  6. 8.1.5 Siemens Healthineers Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare AI Tools for Cancer Therapy Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 ConcertAI
  14. 8.3.1 ConcertAI Company Information
  15. 8.3.2 ConcertAI Business Overview
  16. 8.3.3 ConcertAI AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ConcertAI AI Tools for Cancer Therapy Product Portfolio
  18. 8.3.5 ConcertAI Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic AI Tools for Cancer Therapy Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche AI Tools for Cancer Therapy Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Oracle
  32. 8.6.1 Oracle Company Information
  33. 8.6.2 Oracle Business Overview
  34. 8.6.3 Oracle AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Oracle AI Tools for Cancer Therapy Product Portfolio
  36. 8.6.5 Oracle Recent Developments
  37. 8.7 NVIDIA
  38. 8.7.1 NVIDIA Company Information
  39. 8.7.2 NVIDIA Business Overview
  40. 8.7.3 NVIDIA AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NVIDIA AI Tools for Cancer Therapy Product Portfolio
  42. 8.7.5 NVIDIA Recent Developments
  43. 8.8 Philips
  44. 8.8.1 Philips Company Information
  45. 8.8.2 Philips Business Overview
  46. 8.8.3 Philips AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Philips AI Tools for Cancer Therapy Product Portfolio
  48. 8.8.5 Philips Recent Developments
  49. 8.9 PathAI
  50. 8.9.1 PathAI Company Information
  51. 8.9.2 PathAI Business Overview
  52. 8.9.3 PathAI AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PathAI AI Tools for Cancer Therapy Product Portfolio
  54. 8.9.5 PathAI Recent Developments
  55. 8.10 CureMetrix
  56. 8.10.1 CureMetrix Company Information
  57. 8.10.2 CureMetrix Business Overview
  58. 8.10.3 CureMetrix AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CureMetrix AI Tools for Cancer Therapy Product Portfolio
  60. 8.10.5 CureMetrix Recent Developments
  61. 8.11 Mindpeak
  62. 8.11.1 Mindpeak Company Information
  63. 8.11.2 Mindpeak Business Overview
  64. 8.11.3 Mindpeak AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mindpeak AI Tools for Cancer Therapy Product Portfolio
  66. 8.11.5 Mindpeak Recent Developments
  67. 8.12 Paige AI
  68. 8.12.1 Paige AI Company Information
  69. 8.12.2 Paige AI Business Overview
  70. 8.12.3 Paige AI AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Paige AI AI Tools for Cancer Therapy Product Portfolio
  72. 8.12.5 Paige AI Recent Developments
  73. 8.13 Predictive Oncology
  74. 8.13.1 Predictive Oncology Company Information
  75. 8.13.2 Predictive Oncology Business Overview
  76. 8.13.3 Predictive Oncology AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Predictive Oncology AI Tools for Cancer Therapy Product Portfolio
  78. 8.13.5 Predictive Oncology Recent Developments
  79. 8.14 Exscientia
  80. 8.14.1 Exscientia Company Information
  81. 8.14.2 Exscientia Business Overview
  82. 8.14.3 Exscientia AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Exscientia AI Tools for Cancer Therapy Product Portfolio
  84. 8.14.5 Exscientia Recent Developments
  85. 8.15 Insilico Medicine
  86. 8.15.1 Insilico Medicine Company Information
  87. 8.15.2 Insilico Medicine Business Overview
  88. 8.15.3 Insilico Medicine AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Insilico Medicine AI Tools for Cancer Therapy Product Portfolio
  90. 8.15.5 Insilico Medicine Recent Developments
  91. 8.16 Iktos
  92. 8.16.1 Iktos Company Information
  93. 8.16.2 Iktos Business Overview
  94. 8.16.3 Iktos AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Iktos AI Tools for Cancer Therapy Product Portfolio
  96. 8.16.5 Iktos Recent Developments
  97. 8.17 Tempus
  98. 8.17.1 Tempus Company Information
  99. 8.17.2 Tempus Business Overview
  100. 8.17.3 Tempus AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tempus AI Tools for Cancer Therapy Product Portfolio
  102. 8.17.5 Tempus Recent Developments
  103. 8.18 Azra AI
  104. 8.18.1 Azra AI Company Information
  105. 8.18.2 Azra AI Business Overview
  106. 8.18.3 Azra AI AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Azra AI AI Tools for Cancer Therapy Product Portfolio
  108. 8.18.5 Azra AI Recent Developments
  109. 8.19 CureMatch
  110. 8.19.1 CureMatch Company Information
  111. 8.19.2 CureMatch Business Overview
  112. 8.19.3 CureMatch AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  113. 8.19.4 CureMatch AI Tools for Cancer Therapy Product Portfolio
  114. 8.19.5 CureMatch Recent Developments
  115. 8.20 OncoLens
  116. 8.20.1 OncoLens Company Information
  117. 8.20.2 OncoLens Business Overview
  118. 8.20.3 OncoLens AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  119. 8.20.4 OncoLens AI Tools for Cancer Therapy Product Portfolio
  120. 8.20.5 OncoLens Recent Developments
  121. 8.21 Triomics
  122. 8.21.1 Triomics Company Information
  123. 8.21.2 Triomics Business Overview
  124. 8.21.3 Triomics AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Triomics AI Tools for Cancer Therapy Product Portfolio
  126. 8.21.5 Triomics Recent Developments
  127. 8.22 Clinakos
  128. 8.22.1 Clinakos Company Information
  129. 8.22.2 Clinakos Business Overview
  130. 8.22.3 Clinakos AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Clinakos AI Tools for Cancer Therapy Product Portfolio
  132. 8.22.5 Clinakos Recent Developments
  133. 8.23 Perthera
  134. 8.23.1 Perthera Company Information
  135. 8.23.2 Perthera Business Overview
  136. 8.23.3 Perthera AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Perthera AI Tools for Cancer Therapy Product Portfolio
  138. 8.23.5 Perthera Recent Developments
  139. 8.24 Cellworks Group
  140. 8.24.1 Cellworks Group Company Information
  141. 8.24.2 Cellworks Group Business Overview
  142. 8.24.3 Cellworks Group AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Cellworks Group AI Tools for Cancer Therapy Product Portfolio
  144. 8.24.5 Cellworks Group Recent Developments
  145. 8.25 Biomy
  146. 8.25.1 Biomy Company Information
  147. 8.25.2 Biomy Business Overview
  148. 8.25.3 Biomy AI Tools for Cancer Therapy Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Biomy AI Tools for Cancer Therapy Product Portfolio
  150. 8.25.5 Biomy Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst